There was no change in TDD, however, smaller insulin dose changes may have occurred without any noticeable overall change in total insulin.9 As sensor glucose data were not visible in real-time, the fall in time in hyperglycaemia is likely a direct result of reviewing and discussing retrospective sensor data with the healthcare professional.8 The intrinsic value and advantage of clinical dialogue between patient and clinician supported by ‘pictorial’ examples of glycaemic issues and improvements shown in the glucose reports is the least measurable factor. Here, INS is linked to Hyperglycemia.